Justhome, a next generation home financing startup, has raised €3.3 million in a pre-seed funding round led by Target Global. APX, the Berlin-based early-stage fund backed by Europe’s leading digital publisher Axel Springer and Porsche also participated in the round, alongside a number of industry-leading angel investors.    Launched this year to simplify what can be a confusing and intimidating homebuying process, Justhome is building a digital service to help more people afford a home against a challenging economic backdrop.    The funding will be used to further build out Justhome’s digital home financing platform and develop its own financing

Kain Capital, a private equity firm focused on the technology enablement of healthcare services companies, has completed a growth equity investment in MY DR NOW, a provider of primary and specialty care with locations in Arizona. Financial terms of the investment, which marks the first time MY DR NOW has received external capital, have to been disclosed. Kain Capital is the sole investor.  MY DR NOW serves the greater Phoenix market with over 80 providers at 13 locations. Founded by Dr Payam Zamani while in residency, MY DR NOW is a fully comprehensive, value-based, integrated primary and specialty care platform

Genesis Private Equity Fund IV (GPEF IV), the newest private equity fund of Genesis Capital, and Evolving Europe Principal Investments I (EEPI I), a private equity and growth capital fund advised by Integral Venture Partners, have partnered to acquire 100% of BORCAD cz, a producer of train seats and interior equipment for passenger trains based in Fryčovice, Czech Republic. BORCAD was founded in 1990 as a design and development studio by Ivan Boruta. Now it is a leading European producer of railway technologies offering a full range of seats for personal carriages, ranging from standard seats for regional trains to

Palatine has successfully exited its investment in CTS Group, a provider of testing, inspection and geo-engineering consulting services to the construction and infrastructure sectors, through a sale to pan-European private equity investorOakley Capital. Palatine made a partial exit from the business in 2021, with the sale of its insurance claims management division to HomeServe plc for £53 million. Together the transactions represent a return of 5.8x for Palatine’s investors.    Since its initial investment in 2018, Palatine has grown CTS into a leading business in the UK. Revenues have more than doubled over the last three years, through Palatine’s investment

Oakley Capital’s (Oakley), a pan-European private equity investor, has invested in testing, inspection, certification, and compliance (TICC) platform, Phenna Group (Phenna), in partnership with co-founders Paul Barry (CEO) and David Harrison (CFO) who are reinvesting into the business.

Fortis Solutions Group (Fortis), a provider of high impact printed packaging solutions and a portfolio company of funds managed by Harvest Partners, has acquired Identi-Graphics. Terms of the transaction have not been disclosed. Identi-Graphics is a manufacturer and printer of pressure sensitive labels and flexible packaging products serving the snack, bakery, confectionary, cosmetic and chemical end markets in the US and Canada. The company specialises in the printing of bar wrappers for the nutritional supplement industry, in both heat and cold seal applications.    Employing over 1,200 employees across twenty manufacturing sites, Fortis intends to continue its pursuit of attractive

Neurofenix, a neurological rehabilitation platform that uses sensor technology to improve patient recovery outcomes, has raised $7 million in Series A funding led by AlbionVC, with additional participation by HTH, InHealth Ventures, and existing investors. The funding will enable Neurofenix to build out its product line and invest in US expansion, including funding US clinical trials.  Founded in 2016 by Imperial graduates and Entrepreneur First alumni Guillem Singla Buxarrais (CEO) and Dimitrios Athanasiou (CTO), Neurofenix aims to revolutionise how neurological rehabilitation is delivered to drive better outcomes and recovery for patients.  Neurofenix’s rehab programme currently focuses on arm and hand

Randy Hetrick, the founder and former CEO of global fitness brand TRX, has teamed with private equity veteran Jack Daly, top acquire the business. Hetrick founded TRX after inventing the Suspension Trainer as a SEAL Team Squadron Commander and will now lead the Company as Chairman, while Daly will serve as Chief Executive Officer. Hetrick led TRX for more than 15 years before selling a controlling interest in the Company and moved on to found the new outdoor mobile fitness venture, OutFit. Daly, a former Partner, and Investment Committee Member of both Goldman Sachs’ Merchant Banking Division and TPG Capital,

Gilde Healthcare, a specialised healthcare investor, is to acquire Sanquin Reagents from Sanquin Health Solutions (SHS) with its private equity fund. Sanquin Reagents produces and sells blood group and immune reagents, materials needed for diagnostic research and drug development. Sanquin Reagents is an international producer in the field of hematology and immunology reagents, supplying tests to laboratories for medical diagnostics and research.  The investment by the private equity fund of Gilde Healthcare offers Sanquin Reagents the opportunity to scale up the production of diagnostic tests and to strengthen its leading position in the development of immunoreagents. Sanquin Reagents will remain

Avance Investment Management (Avance), a private equity firm that invests in founder-owned, middle market businesses in the services, technology and consumer sectors, has made a strategic investment in RIA Advisory (RIA), a provider of revenue management solutions. Financial terms of the transaction have not been disclosed.   Founded in late 2016 with the goal of transforming revenue management for large and mid-size enterprises, RIA has established itself as the leading partner of choice for a wide range of Fortune 100 Companies – including numerous blue chip customers. RIA provides a leading portfolio of diversified offerings, implementing highly scalable Oracle platforms